The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis

详细信息    查看全文

• 作者：Elena Nicolis (1)
  Matteo Pasetto (1)
  Cristina Cigana (1)
  Ugo Pradal (1)
  Baroukh M Assael (1)
  Paola Melotti (1)
  
• 刊名：BMC Medical Genetics
• 出版年：2006
• 出版时间：December 2006
• 年：2006
• 卷：7
• 期：1
• 全文大小：671KB
• 参考文献：1. Lindsell PHJ: Glutathione permeability of CFTR. / Am J Physiol 1998, 275:C323.
  2. Gao LKK, Yankaskas JR, Forman HJ: Abnormal glutathione transport in cystic fibrosis airway epithelia. / Am J Physiol 1999, 277:L113.
  3. Altschuler EL: Azithromycin, the multidrug-resistant protein, and cystic fibrosis. / Lancet 1998, 351:1286. CrossRef
  4. Lallemand JY, Stoven V: Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? / Lancet 1997, 350:711鈥?12. CrossRef
  5. Hurbain I, Sermet-Gaudelus I: Evaluation of MRP1鈥? gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. / Pediatr Res 2003, 54:627鈥?34. CrossRef
  6. Pradal U, Cipolli M, Cazzola G: Chloride transport may be restored by long-term azithromycin treatment in patients with cystic fibrosis. / Pediatr Pulmonol 2000, (Suppl 20):280.
  7. Pradal U, Delmarco A: Long term azithromycin in cystic fibrosis: another possible mechanism of action? / J Chemother 2005, 17:384鈥?00.
  8. Pradal U, Delmarco A: Azithromycin induces over-expression of multidrug resistance-associated protein (MRP) and restores chloride conductance in cystic fibrosis [abstract]. / J Cystic Fibrosis 2002, 1:s52.
  9. Zhu Q, Center MS: Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. / Cancer Res 1994, 54:4488鈥?492.
  10. Kruh GD, Gaughan KT: Expression pattern of MRP in human tissues and adult solid tumor cell lines. / J Natl Cancer Inst 1995, 87:1256鈥?258. CrossRef
  11. Dean M, Rzhetsky A: The human ATP-binding cassette (ABC) transporter superfamily. / Genome Res 2001, 11:1156鈥?166. CrossRef
  12. Loe DW, Deeley RG: Biology of the multidrug resistance-associated protein, MRP. / Eur J Cancer 1996, 32A:945鈥?57. CrossRef
  13. Venkatakrishnan ASA, King G, Blackwell TR, Bringham KL, Christman JW, Blackwell TS: Exaggerated activation of NF-kB and altered IkB-beta processing in cystic fibrosis bronchial epithelial cells. / American Journal of Respiratory Cell Molecular Biology 2000, 23:396鈥?03.
  14. Henrion A, Flamant C, Roussey M, Strange RC, Chadelat K, Clement A: Severity of cystic fibrosis is associated with gene polymorphism of anti-oxidizing enzymes [abstract]. / Pediatr Pulmonol 2001, 22:s215.
  15. Baranov VS, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, Malet P, Perriot J, Mouraire P, Baskakov VN, Savitskyi GA, Gorbushin S, Deyneka SI, Michnin E, Barchuck A, Vakharlovsky V, Pavlov G, Shilko VI, Guembitzkaya T, Kovaleva L: Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. / Hum Genet 1996, 97:516鈥?20. CrossRef
  16. Jirsch JR, Deeley G: Inwardly rectifying K+ channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells. / Cancer Res 1993, 53:4156鈥?160.
  17. Hainsworth AH, Henderson RM: Hypotonicity-induced anion fluxes in cells expressing the multidrug-resistance-associated protein, MRP. / Pflugers Arch 1996, 432:234鈥?40. CrossRef
  18. Borst P, Kool RE, Wijnholds M: A family of drug transporters: the multidrug resistance-associated proteins. / J Natl Cancer Inst 2000, 92:1295鈥?302. CrossRef
  19. Leslie EM, Cole SP: Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. / Toxicology 2001, 67:3鈥?3. CrossRef
  20. Wijnholds J, van Leudsen MR, Mol CA, Zaman GJ, Mayer U, Beijnen J, der Valk M, Krimpenfort P, Borst P: Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. / Nat Med 1997, 3:1275鈥?279. m1197-1275">CrossRef
  21. Miller SA, Dykes DD: A simple salting out procedure for extracting DNA from human nucleated cells. / Nucleic Acids Res 1988, 16:1215. CrossRef
  22. Cipolli M, Novelli G, Cassetta MI, Fallani S, Mazzei T: Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis. / Clin Drug Invest 2001, 21:353. CrossRef
  23. Wang Z, Wang B, Tang K, Lee EJD, Chong SS, Lee CGL: A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection. / Hum Mol Gen 2005, 14:2075鈥?087. mg/ddi212">CrossRef
  24. Zaldivar F, Nugent DJ: Identification of a novel regulatory element in the human interleukin 1 alpha (IL-1alpha) gene promoter. / Cytokine 2002, 20:130鈥?35. CrossRef
  25. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB: Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. / Cancer Res 1994, 54:5607鈥?613.
  26. The pre-publication history for this paper can be accessed here:medcentral.com/1471-2350/7/7/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-2350/7/7/prepub
  
• 作者单位：Elena Nicolis (1)
  Matteo Pasetto (1)
  Cristina Cigana (1)
  Ugo Pradal (1)
  Baroukh M Assael (1)
  Paola Melotti (1)
  
  1. Cystic Fibrosis Center, Azienda Ospedaliera di Verona, Piazzale Stefani 1, 37126, Verona, Italy
  
• ISSN：1471-2350

文摘

Background Among the members of the ATP binding cassette transporter superfamily, MRPs share the closest homology with the CFTR protein, which is defective in CF disease. MRP1 has been proposed as a potential modifier gene and/or as novel target for pharmacotherapy of CF to explain the clinical benefits observed in some CF patients treated with the macrolide AZM. The 5'UTR of the MRP1 gene contains a GCC triplet repeat that could represent a polymorphic site and affect the activity of the promoter. Methods The MRP1 5' flanking region was amplified by PCR from 36 CF patients and 100 non-CF subjects and the number of GCC triplets of each allele was determined by sequence and electrophoretic analysis. We performed gene reporter studies in CF airway epithelial cells 16HBE14o-AS3, in basal conditions and in the presence of AZM. Results We found that the GCC repeat is polymorphic, ranging from 7 to 14 triplets either in CF or in non-CF subjects. Our data are preliminary and have to be confirmed on a larger population of CF subjects. The transcriptional activity of the proximal MRP1 5' regulatory region revealed no statistically significant correlations between the number of repeats and treatment with AZM. Conclusion We identified a novel polymorphism in the 5'UTR of MRP1 gene that provides multiple alleles in a gene relevant for multidrug resistance as well as for CF, determining that this region is transcriptionally active and that this activity does not appear to be influenced by AZM treatment.